Stock listing

NASDAQ:TSRO Tesaro Inc Stock

Follow Tesaro Inc into a list and get an email when it puts out news.

Last close · NASDAQ:TSRO

$74.96 USD

Close on Jan 18, 2019 · No longer trades

Jun 28, 2012 to last close +447.6% · weekly closes, Jun 28, 2012 – Jan 18, 2019
Lowest – highest close
$11.25 – $190.36 USDSince Jun 28, 2012 · lowest Aug 29, 2012 · highest Feb 17, 2017

Delisted NASDAQ:TSRO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:TSRO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Tesaro Inc on 6ix

Decks
12 decks · latest Jan 8, 2018

Decks

DeckKindSlidesDate
Investor Presentation (January 2018)Investor deck47 slidesJan 8, 2018
Investor Presentation (March 2016)Investor deck66 slidesMar 16, 2016
Q4 2015 Earnings PresentationEarnings22 slidesFeb 25, 2016
Conference Call with Clients of Leerink Partners (October 2015)Conference11 slidesOct 15, 2015
Q3 2014 Earnings PresentationEarnings15 slidesNov 5, 2014
Q2 2014 Earnings PresentationEarnings17 slidesJul 24, 2014
Q1 2014 Earnings PresentationEarnings18 slidesApr 30, 2014
Merger or Acquisition (March 2014)Merger or acquisition20 slidesMar 13, 2014
Investor Presentation (January 2014)Investor deck27 slidesJan 8, 2014
Q3 2013 Earnings PresentationEarnings24 slidesNov 7, 2013
All 12 decks
DeckKindSlidesDate
Technical Presentation (February 2013)Technical10 slidesFeb 14, 2013
Investor Presentation (January 2013)Investor deck29 slidesJan 7, 2013

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Beth C Seidenberg
Other companies: Latigo Biotherapeutics, Inc. (Director · Since at least Aug 6, 2026); Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Sagimet Biosciences Inc. - Series A (Director · Since at least Jul 13, 2023); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); Atara Biotherapeutics, Inc. (Director · Oct 15, 2014 – May 31, 2023 · Past); Epizyme Inc (Director · May 30, 2013 – Jun 30, 2019 · Past)
Director · Jun 27, 2012 – Jan 22, 2019 · Past
Mary Lynne Hedley
Other companies: Eli Lilly and Company (Director · Since at least May 15, 2022); Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Veeva Systems Inc. (Director · Since at least Aug 16, 2019); Tempest Therapeutics, Inc. (Director · Dec 7, 2018 – Jun 22, 2020 · Past); Bluebird bio Inc (Director · Sep 18, 2017 – Jun 20, 2018 · Past); Receptos Inc (Director · Apr 11, 2014 – Aug 27, 2015 · Past); Abraxis BioScience Inc (Executive VP of Ops & CSO · Jul 9, 2009 – Jul 13, 2009 · Past)
President & COO, Director · Jun 27, 2012 – Jan 22, 2019 · Past
Lawrence M. Alleva
Other companies: Galera Therapeutics, Inc. (Director · Since at least Nov 6, 2019); Mersana Therapeutics Inc (Director · Since at least Sep 5, 2017); Bright Horizons Family Solutions Inc. (Board Member · Since at least May 12, 2016); Adaptimmune Therapeutics PLC (Chairman and Non-Executive Director · Since at least Jan 1, 2016); Synlogic Inc (Director · Sep 30, 2015 – Jun 29, 2016 · Past)
Director · Jun 1, 2016 – Jan 22, 2019 · Past
Leon O Moulder Jr
Other companies: Zenas BioPharma, Inc. (See Remarks, Director · Since at least Sep 12, 2024); Zai Lab Ltd. (Director · Since at least Jan 1, 2021); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – May 23, 2024 · Past); Trevena, Inc. (Director · May 16, 2018 – Jun 15, 2023 · Past)
Chief Executive Officer, Director · Mar 1, 2018 – Jan 22, 2019 · Past
Pascale Witz
Other companies: Revvity, Inc. (Director · Since at least Oct 27, 2017); Regulus Therapeutics Inc (Director · Since at least Jun 1, 2017); Horizon Pharma PLC (Director · Aug 2, 2017 – Aug 2, 2018 · Past)
Director · May 10, 2018 – Jan 22, 2019 · Past
Jeffrey H HankeExecutive VP, R&D and CSO · Jun 29, 2015 – Aug 30, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Tesaro Inc.